DV
Dividend Vision

AVIR — Atea Pharmaceuticals Inc

Atea Pharmaceuticals Inc (AVIR)

Total return is -83.1% over the past 5.8 years, 240.2 points behind SPY at 157.1%. Its deepest 1-year drawdown was 33.3%.

AVIR is a single-stock equity fund that tracks Atea Pharmaceuticals Inc, a biopharmaceutical company. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. This holding appeals primarily to investors seeking exposure to a specific pharmaceutical company rather than those pursuing dividend yield strategies.

AVIR key facts

Asset type
Stock
Asset class
Equity
Inception date
10/30/2020
Last close
$5.12
Market cap
$389,731,936
Average volume
249600.0
Beta
0.316
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.11